Using AI to Check Medicine Interactions
Learn how to use AI tools to check for possible medicine interactions and ensure safer drug combinations with our step-by-step…
Part of the
network
network
Tag: Drug Safety
Merck Tactics On Vioxx Exposed
The drugmaker encouraged its sales team to accentuate the positive about the painkiller and minimize discussion of potential heart risks.
FDA Expands Risk Info On Celebrex Label
The FDA is expanding the risk information on Pfizer's Celebrex label, and the company plans to have further discussions with…
Elan and Biogen Suspend Marketeing of TYSABRI
Elan and Biogen Idec's ongoing safety evaluation of TYSABRI has led to a previously diagnosed case of malignant astrocytoma being…
Merck Getting By With or Without VIOXX
Even with the elimination of VIOXX, Merck managed growth in revenue for the fourth quarter.
TheraSTrat Announces SafeBase 2.5 Professional
The theragenomics company TheraSTrat is pleased to announce the commercial availability of SafeBase 2.5 Professional.
SEO Case Study: Attorneys Chasing Vioxx Organic Search Ranking
Last week the drug manufacturer Merck pulled their pain relief medication Vioxx (rofecoxib) from the market due to studies linking…
